Angeliq Regulatory Post Marketing Surveillance
NCT01064453
·
clinicaltrials.gov ↗
COMPLETED
Status
4078
Enrollment
INDUSTRY
Sponsor class
Conditions
Postmenopausal Period
Osteoporosis, Postmenopausal
Interventions
DRUG:
E2/DRSP (Angeliq, BAY86-4891)
Sponsor
Bayer